We are live on ! Find out more
EPIX

ESSA Pharma
EPIX

Delisted

EPIX was delisted on the 8th of October, 2025.

Back to rankings

35 hedge funds and large institutions have $139M invested in ESSA Pharma in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

75% more funds holding

Funds holding: 20 → 35 (+15)

61% more capital invested

Capital invested by funds: $86.5M → $139M (+$52.6M)

2.53% more ownership

Funds ownership: 67.51% → 70.04% (+2.5%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
35
Holders Change
+15
Holders Change %
+75%
% of All Funds
0.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
11
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$14.2M
2
VC
Vivo Capital
California
+$10.3M
3
BI
BVF Inc
California
+$6.93M
4
SCM
Sio Capital Management
New York
+$4.45M
5
Citadel Advisors
Citadel Advisors
Florida
+$2.73M

Top Sellers

Rank Fund Capital Flow
1
OFM
Omega Fund Management
Massachusetts
-$3.97M
2
RCM
RA Capital Management
Massachusetts
-$2.57M
3
O
OrbiMed
New York
-$2M
4
SCM
Soleus Capital Management
Connecticut
-$1.73M

EPIX Hedge Fund Activity: Q3 2020 in Review

35 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in ESSA Pharma (EPIX) for Q3 2020, worth a combined $139M — up 61% from $86.5M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new EPIX positions and 0 closed out — a net gain of 15 holders — while 11 added to existing stakes and 4 trimmed.

The largest buyer was Avidity Partners Management, opening a new position worth an estimated $14.2M. The largest seller was Omega Fund Management, cutting an estimated $3.97M.

  • 35 institutional investors held ESSA Pharma (EPIX) as of Q3 2020, up from 20 in Q2 2020.
  • Funds reported $139M of ESSA Pharma stock for Q3 2020, up 61% quarter-over-quarter.
  • 15 funds opened new ESSA Pharma positions in Q3 2020 and 0 closed out, a net change of +15 holders.
  • The largest ESSA Pharma buyer in Q3 2020 was Avidity Partners Management, an estimated $14.2M added.
  • The largest ESSA Pharma seller in Q3 2020 was Omega Fund Management, an estimated $3.97M sold.

Based on aggregated 13F filings for Q3 2020.